Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.650
-0.110 (-6.25%)
At close: Nov 17, 2026, 4:00 PM EST
1.640
-0.010 (-0.61%)
After-hours: Nov 17, 2026, 4:18 PM EST

Silexion Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2013FY 2012
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
Operating Income
-14.13-11.63-12.57-4.68-1.36-0.95
Net Income
-13.96-11.91-16.44-4.94-1.36-0.94

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2013FY 2012
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
Cash & Investments
2.235.991.194.60.791.6
Total Debt
1.412.044.490.17--
Net Cash (Debt)
0.823.96-3.34.420.791.6
Net Cash Growth
-69.33%--461.42%-50.69%-

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2013FY 2012
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
Operating Cash Flow
-12.43-10.82-8.4-4.53-0.79-0.91
Capital Expenditures
-0-0.01-0.02-0.01-0.01-0
Free Cash Flow
-12.43-10.83-8.42-4.54-0.8-0.91
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.